Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 18.39B 2.72B 2.37B 2.19B 2.05B 3.85B 256B 3.88B 26.03B 10.09B 126B 10.2B 9.98B 438B P/E 2026 *
12.4x
P/E 2027 * 10.8x
Enterprise Value 14.87B 2.2B 1.92B 1.77B 1.66B 3.12B 207B 3.13B 21.05B 8.16B 102B 8.25B 8.07B 354B EV / Sales 2026 *
0.5x
EV / Sales 2027 * 0.43x
Free-Float
34.77%
Yield 2026 *
5.58%
Yield 2027 * 5.88%
Apr. 24 Dashenlin Pharma's Q1 Profit Rises 11% MT
Apr. 24 Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% MT
Apr. 23 DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
Apr. 23 Dashenlin pharmaceutical 2025 net profit up 35.0% y/y RE
Apr. 22 Sipai Health to Sell Stake in Pharmacy Operator to Dashenlin Pharmaceutical For RMB 51.7 Million MT
Apr. 22 DaShenLin Pharmaceutical Group Co., Ltd. signed a equity transfer agreement to acquire Sipai Zhihe Technology Co., Ltd. from Sipai Healthcare Investment Group Co., Ltd. for CNY 79.1 million. CI
25-10-29 DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-08-28 DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-04-25 DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-25 DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
24-10-15 DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 CI
24-09-19 Tranche Update on DaShenLin Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on May 7, 2024. CI
24-09-17 DaShenLin Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on May 7, 2024, has closed with 6,722,254 shares, representing 0.59% for CNY 100.72 million. CI
1 day+0.50%
1 week-6.00%
Current month-2.12%
1 month-9.22%
3 months-11.26%
6 months-12.47%
Current year-8.34%
1 week 15.83
Extreme 15.83
17.4
1 month 15.34
Extreme 15.34
18.35
Current year 15.34
Extreme 15.34
21.78
1 year 15.34
Extreme 15.34
21.78
3 years 11.92
Extreme 11.92
30.22
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.0028
61.63
Manager TitleAgeSince
Chief Executive Officer 44 2019-02-27
Director of Finance/CFO 44 2018-05-09
Human Resources Officer 48 -
Director TitleAgeSince
Chairman 59 2013-07-15
Director/Board Member 63 2016-08-07
Chairman 48 2015-05-27
Change 5-day change 1-year change 3-year change Capi.($)
+0.50%-6.00%+3.66%-43.05% 2.72B
-0.90%-7.04%-11.25%-34.70% 14.31B
-1.79%-5.98%-23.61%-33.87% 6.81B
-0.26%-0.06%-18.57%-13.61% 5.71B
+0.61%-8.51%-15.61%-36.98% 3.57B
+3.24%+3.22%-32.19%-7.97% 3.35B
-1.24%+1.38%-23.96%-43.82% 3.31B
-2.28%-1.58%+115.50% - 2.69B
+3.90%+1.73%+8.91%+43.91% 1.71B
-1.19%+35.91%-26.44%-27.47% 1.55B
Average +0.06%+1.47%-2.36%-21.95% 4.57B
Weighted average by Cap. -0.38%-2.39%-8.23%-27.72%

Financials

2026 *2027 *
Net sales 29.97B 4.43B 3.86B 3.58B 3.35B 6.28B 418B 6.32B 42.42B 16.44B 206B 16.62B 16.26B 714B 33.2B 4.91B 4.28B 3.96B 3.71B 6.95B 463B 7B 46.99B 18.21B 228B 18.41B 18.02B 791B
Net income 1.48B 219M 191M 177M 166M 311M 20.7B 313M 2.1B 814M 10.19B 823M 806M 35.37B 1.7B 251M 219M 203M 190M 357M 23.73B 359M 2.41B 934M 11.68B 944M 924M 40.56B
Net Debt -3.52B -520M -453M -420M -393M -737M -49.06B -742M -4.98B -1.93B -24.15B -1.95B -1.91B -83.85B -4.01B -592M -517M -478M -448M -840M -55.9B -845M -5.67B -2.2B -27.51B -2.22B -2.18B -95.53B
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
26-06-18 16.15 ¥ +0.50% 5,794,947
26-06-17 16.07 ¥ -3.13% 5,294,374
26-06-16 16.59 ¥ -0.54% 4,777,290
26-06-15 16.68 ¥ -2.91% 7,860,601
26-06-12 17.18 ¥ +4.44% 8,491,177
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
16.15CNY
Average target price
24.49CNY
Spread / Average Target
+51.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!